A Comprehensive Trauma-sensitive Approach to Physical Activity Promotion in Schools (CSPAP-T)
NCT ID: NCT05382975
Last Updated: 2024-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
8000 participants
INTERVENTIONAL
2022-08-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Be a Champion! Comprehensive School Physical Activity Program
NCT02465372
The CHAMP ASP: Promoting Physical Activity & Health in Children
NCT05342701
Attention Capacity and Before-school Physical Activity Intervention Program
NCT03893149
The Use of Data From Wearable Technology to Co-develop School-specific Physical Activity Interventions
NCT04905615
Efficacy of Increasing Physical Activity to Reduce Children's Visceral Fat
NCT00359957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The effectiveness and implementation of a flexible, systems-level intervention to increase opportunities for trauma-sensitive PA in middle schools will be studied. The intervention seeks to support middle schools in increasing opportunities for trauma-sensitive PA practices in all CSPAP domains-addressing two core systems-level barriers to such implementation (staffing and teacher/staff training) and building in flexibility for setting-specific needs assessment and action planning. Core components include (1) provision of a dedicated staff member (via Americorps) to support school PA (via direct staffing and capacity building), (2) setting-specific needs assessment and action planning, and (3) professional development opportunities for teachers, staff, and coaches related to the provision of trauma-sensitive PA.
The study will use a stepped wedge design with a total of 8 middle schools, in which each school will be randomized to start the intervention at different time points. All schools will provide baseline data and will later switch to the intervention phase in random order and in 3 waves. Based on feasibility considerations, 2 schools will switch from control phase to intervention phase in wedge 1, 3 schools will be in wedge 2, and 3 schools will be in wedge 3. Each 2-year intervention phase will be followed by a year when data will be collected to assess sustainability of the intervention. In total, there will be 20 control phase data collections, 24 intervention phase data collections, and 16 data collections during maintenance phase, for a total of 1800 student-assessments (across all schools and all time periods for 20 control and 40 intervention or post-intervention periods). This study will:
1. Assess how intervention exposure is associated with student (accelerometer-measured) PA
2. Assess how intervention exposure is associated with student internalizing and externalizing symptoms and resilient psychosocial function functioning
3. Assess how intervention exposure is associated with change in PA opportunities at the school level
4. Explore systems-level barriers and facilitators to successful intervention implementation and maintenance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wedge 1 includes Schools 1 and 2.
CSPAP-T
Trauma-adapted CSPAP delivery:
* Staffing support
* Trauma-sensitive professional development for teachers and staff
* Setting specific needs assessment and action planning
Wedge 2 includes Schools 3, 4, and 5.
CSPAP-T
Trauma-adapted CSPAP delivery:
* Staffing support
* Trauma-sensitive professional development for teachers and staff
* Setting specific needs assessment and action planning
Wedge 3 includes Schools 6, 7, and 8.
CSPAP-T
Trauma-adapted CSPAP delivery:
* Staffing support
* Trauma-sensitive professional development for teachers and staff
* Setting specific needs assessment and action planning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CSPAP-T
Trauma-adapted CSPAP delivery:
* Staffing support
* Trauma-sensitive professional development for teachers and staff
* Setting specific needs assessment and action planning
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attend one of the participating schools during the study period
* Age 18 or older
* Work at one of the participating schools during the study period
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seattle Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pooja Tandon
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seattle Children's Research Institute
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00003419
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.